Reports for TEVA CANADA LIMITED
Company Name
TEVA CANADA LIMITED
Totals |
||
Shortage reports |
2684 |
|
Actual shortage: | 240 (9%) | |
Anticipated shortage: | 0 (0%) | |
Avoided shortage: | 9 (0%) | |
Resolved: | 2435 (91%) | |
Discontinuation Reports |
250 |
|
To be discontinued: | 3 (1%) | |
Discontinued: | 247 (99%) | |
Reversed: | 0 (0%) | |
Late reports |
330 (11%) |
|
Overdue reports |
24 (10%) |
Shortage reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-FAMOTIDINE | 40MG | TABLET | Resolved | 2019-09-26 | 2020-03-10 | 94880 |
ACT NABILONE | 0.5MG | CAPSULE | Resolved | 2019-12-19 | 2020-03-12 | 101740 |
ACT NABILONE | 1MG | CAPSULE | Resolved | 2019-12-19 | 2020-03-12 | 101730 |
ACT NABILONE | 1MG | CAPSULE | Resolved | 2019-10-17 | 2020-03-12 | 96733 |
ACT CELECOXIB | 100MG | CAPSULE | Resolved | 2019-08-22 | 2020-03-12 | 92235 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2019-12-12 | 2020-03-12 | 101148 |
TEVA-ERLOTINIB | 100MG | TABLET | Resolved | 2020-01-30 | 2020-03-12 | 104896 |
TEVA-ESCITALOPRAM | 10MG | TABLET | Resolved | 2020-02-13 | 2020-03-12 | 106008 |
TEVA-ESCITALOPRAM | 20MG | TABLET | Resolved | 2020-02-21 | 2020-03-12 | 106948 |
TEVA-BROMAZEPAM | 6MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107952 |
TEVA-BISOPROLOL | 5MG | TABLET | Resolved | 2020-01-17 | 2020-03-12 | 103558 |
TEVA-TADALAFIL | 2.5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107955 |
TEVA-ELETRIPTAN | 20MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107961 |
TEVA-OXYCOCET | 325MG 5MG | TABLET | Resolved | 2020-03-06 | 2020-03-12 | 107989 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-09-12 | 2020-03-16 | 61368 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68626 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68632 |
ETOPOSIDE INJECTION | 20MG | LIQUID | Resolved | 2018-12-04 | 2020-03-16 | 68629 |
TEVA-FLUVASTATIN | 40MG | CAPSULE | Resolved | 2019-01-08 | 2020-03-19 | 71553 |
TEVA-TOLTERODINE LA | 4MG | CAPSULE (EXTENDED RELEASE) | Resolved | 2020-01-30 | 2020-03-19 | 104902 |
Discontinuation reports
Brand name | Strength | Dosage | Status | Date Created | Date Updated | Reports |
---|---|---|---|---|---|---|
TEVA-NYSTATIN | 100000UNIT | SUSPENSION | Discontinued | 2018-10-12 | 2018-10-12 | 63949 |
TEVA-CIPROFLOXACIN | Discontinued | 2018-10-12 | 2018-10-12 | 63952 | ||
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63955 |
NOVASEN | 325MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63959 |
NOVASEN | 650MG | TABLET (DELAYED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63964 |
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63967 | ||
GEMCITABINE FOR INJECTION | Discontinued | 2018-10-12 | 2018-10-12 | 63970 | ||
TEVA-LISINOPRIL/HCTZ (TYPE P) | 12.5MG 10MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63975 |
TEVA-LISINOPRIL (TYPE P) | 20MG | TABLET | Discontinued | 2018-10-12 | 2018-10-12 | 63978 |
ACT OXYCODONE CR | 10MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63983 |
ACT OXYCODONE CR | 20MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63986 |
ACT OXYCODONE CR | 40MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63989 |
ACT OXYCODONE CR | 80MG | TABLET (EXTENDED-RELEASE) | Discontinued | 2018-10-12 | 2018-10-12 | 63992 |
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64520 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64526 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64529 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64532 | ||
ACT ESCITALOPRAM | Discontinued | 2018-10-17 | 2018-10-17 | 64535 | ||
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64538 |
TEVA-ATORVASTATIN | 40MG | TABLET | Discontinued | 2018-10-17 | 2018-10-17 | 64541 |